Optos, a leading medical retinal imaging company based in the UK, has announced the acquisition of the Australian based Opto Global Holdings Pty Ltd for up to USD$14.75 million.
Optos says it will be able to expand the market for Opto Global’s products in the U.S. and EU markets and will also promote its own products in Opto Global’s international markets in the Far and Middle East, Australasia, Africa and Latin America.
Roy Davis, CEO of Optos said “We expect the impact of this transaction to be earnings enhancing in the current financial year. This represents an important step in our journey to becoming a leading provider of diagnostic and treatment solutions to the ophthalmic community.”
Opto Global is an ophthalmic device company based in South Australia that designs, develops, sources and sells precision optometric and ophthalmic equipment that covers the diagnosis and treatment in the four main areas of ophthalmology; glaucoma, cataract, refractive and retina.
